Cyberounds Logo
September 18, 2019 | LOGIN | REGISTER | HELP | 


email a friend print Bookmark and Share
Liver Fibrosis: New Mechanisms, New Treatments, and Why They Matter
CME credit is no longer available for this conference.
Rebecca G. Wells, M.D.

Dr. Wells is Assistant Professor of Medicine (Gastroenterology), University of Pennsylvania School of Medicine, Philadelphia, PA.

Dr. Wells reports no conflicts of interest.


Release Date: 08/15/2007
Termination Date: 08/15/2010

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss current thinking about the mechanisms of fibrosis
  • Discuss new modalities for diagnosing fibrosis
  • Discuss evidence supporting the possibility of fibrosis regression
  • Discuss new treatment options for fibrosis, and understand their relationship to concepts of regression.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity